Tirzepatide
Benefits of Compounded Tirzepatide for Weight Loss:
Improved Glycemic Control: Tirzepatide, like other GLP-1 receptor agonists, is known for its ability to enhance insulin secretion, reduce glucagon production, and slow down gastric emptying. This can lead to better control of blood sugar levels in individuals with type 2 diabetes, and improved glycemic control is often associated with weight loss.
Appetite Suppression: GLP-1 receptor agonists, including tirzepatide, are thought to have an impact on appetite regulation. By influencing the brain’s satiety centers, these medications can lead to reduced feelings of hunger, which may contribute to weight loss.
Weight Loss: Clinical trials have shown promising results regarding weight loss with tirzepatide. In some studies, tirzepatide has demonstrated greater weight loss compared to other diabetes medications. The weight loss effect is believed to result from a combination of reduced calorie intake, increased energy expenditure, and potential changes in fat metabolism.
Key Benefits
- Participants in the study lost over 20% of their body weight.
- Participants experienced improved control over food cravings and compulsion
- Lowered their risk of cardiovascular disease (heart attack or stroke)
- Lowered lifetime risk of osteoporosis
- General improvement in mental health
Tirzepatide with B12 has three basic mechanisms of action:
- Tirzepatide with B12 slows down your stomach causing you to feel full longer.
- Tirzepatide with B12 increases insulin sensitivity, this makes your body more efficient at processing blood sugar
- Tirzepatide with B12 helps you leave the clean plate club! It helps patients not feel compelled to finish all the food on their plate.
Frequently Asked Questions:
It lowers your blood sugar. It signals to the brain that you’re full. And it slows the digestion of your food through your stomach so you feel fuller longer.
This is for people who struggle with overeating, and for those who have implemented an exercise or nutrition program with minimal impact. Our experienced healthcare providers will thoroughly review your medical history and overall health to tailor a plan best for you.
A: This is a once-per-week subcutaneous injection.
The recommended starting dose of Tirzepatide is 2.5 mg administered once weekly. After four weeks, the dose can be increased to 5 mg once weekly. Further dose adjustments can be made in increments of 2.5 mg after at least four weeks on the current dose, based on glycemic response and tolerability, up to a maximum dose of 15 mg once weekly.
Tirzepatide mimics two gut hormones: GLP-1 and GIP where Semaglutide only mimics GLP-1. These gut hormones help regulate the amount of insulin secreted after eating.
Contact WITH US
We’d love to hear from you! Please send us a message using the form provide, Click Here for virtual consultation.
Healthy Habits Wellness Clinic
- 19116 location, NE Philadelphia
- 215 880 8573
Business hours
Opened Sun to Fri Morning and Evening by appointment.